Pathophysiologic and prognostic importance of cardiac power output reserve in heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power output (CPO) is an index of global cardiac performance and can be estimated non-invasively by echocardiography. We hypothesized that CPO reserve d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal cardiovascular imaging Jg. 25; H. 2; S. 220
Hauptverfasser: Takizawa, Daiki, Harada, Tomonari, Obokata, Masaru, Kagami, Kazuki, Sorimachi, Hidemi, Yuasa, Naoki, Saito, Yuki, Murakami, Fumitaka, Naito, Ayami, Kato, Toshimitsu, Wada, Naoki, Ishii, Hideki
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England 29.01.2024
Schlagworte:
ISSN:2047-2412, 2047-2412
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power output (CPO) is an index of global cardiac performance and can be estimated non-invasively by echocardiography. We hypothesized that CPO reserve during exercise would be associated with impaired cardiovascular reserve, exercise intolerance, and adverse outcomes in HFpEF. Exercise stress echocardiography was performed in 425 dyspnoeic patients [217 HFpEF and 208 non-heart failure (HF) controls] to estimate CPO at rest and during exercise. We classified patients with HFpEF based on the median value of changes in CPO from rest to peak exercise (ΔCPO >0.49 W/100 g). Patients with HFpEF and a lower CPO reserve had poorer biventricular systolic function, impaired chronotropic response during exercise, and worse aerobic capacity than controls and those with a higher CPO reserve. During a median follow-up of 358 days, a composite outcome of all-cause mortality or HF events occurred in 30 patients. Patients with a lower CPO reserve had four-fold and nearly 10-fold increased risks of the outcomes compared with those with a higher CPO reserve and controls, respectively [hazard ratio (HR) 4.05, 95% confidence interval (CI) 1.16-10.1, P = 0.003 and HR 9.61, 95% CI 3.58-25.8, P < 0.0001]. We further found that a lower CPO reserve had an incremental prognostic value over the H2FPEF score and exercise duration. In contrast, resting CPO did not predict clinical outcomes in patients with HFpEF. A lower CPO reserve was associated with biventricular systolic dysfunction, chronotropic incompetence, exercise intolerance, and adverse outcomes in patients with HFpEF.
AbstractList Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power output (CPO) is an index of global cardiac performance and can be estimated non-invasively by echocardiography. We hypothesized that CPO reserve during exercise would be associated with impaired cardiovascular reserve, exercise intolerance, and adverse outcomes in HFpEF. Exercise stress echocardiography was performed in 425 dyspnoeic patients [217 HFpEF and 208 non-heart failure (HF) controls] to estimate CPO at rest and during exercise. We classified patients with HFpEF based on the median value of changes in CPO from rest to peak exercise (ΔCPO >0.49 W/100 g). Patients with HFpEF and a lower CPO reserve had poorer biventricular systolic function, impaired chronotropic response during exercise, and worse aerobic capacity than controls and those with a higher CPO reserve. During a median follow-up of 358 days, a composite outcome of all-cause mortality or HF events occurred in 30 patients. Patients with a lower CPO reserve had four-fold and nearly 10-fold increased risks of the outcomes compared with those with a higher CPO reserve and controls, respectively [hazard ratio (HR) 4.05, 95% confidence interval (CI) 1.16-10.1, P = 0.003 and HR 9.61, 95% CI 3.58-25.8, P < 0.0001]. We further found that a lower CPO reserve had an incremental prognostic value over the H2FPEF score and exercise duration. In contrast, resting CPO did not predict clinical outcomes in patients with HFpEF. A lower CPO reserve was associated with biventricular systolic dysfunction, chronotropic incompetence, exercise intolerance, and adverse outcomes in patients with HFpEF.
Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power output (CPO) is an index of global cardiac performance and can be estimated non-invasively by echocardiography. We hypothesized that CPO reserve during exercise would be associated with impaired cardiovascular reserve, exercise intolerance, and adverse outcomes in HFpEF.AIMSHeart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power output (CPO) is an index of global cardiac performance and can be estimated non-invasively by echocardiography. We hypothesized that CPO reserve during exercise would be associated with impaired cardiovascular reserve, exercise intolerance, and adverse outcomes in HFpEF.Exercise stress echocardiography was performed in 425 dyspnoeic patients [217 HFpEF and 208 non-heart failure (HF) controls] to estimate CPO at rest and during exercise. We classified patients with HFpEF based on the median value of changes in CPO from rest to peak exercise (ΔCPO >0.49 W/100 g). Patients with HFpEF and a lower CPO reserve had poorer biventricular systolic function, impaired chronotropic response during exercise, and worse aerobic capacity than controls and those with a higher CPO reserve. During a median follow-up of 358 days, a composite outcome of all-cause mortality or HF events occurred in 30 patients. Patients with a lower CPO reserve had four-fold and nearly 10-fold increased risks of the outcomes compared with those with a higher CPO reserve and controls, respectively [hazard ratio (HR) 4.05, 95% confidence interval (CI) 1.16-10.1, P = 0.003 and HR 9.61, 95% CI 3.58-25.8, P < 0.0001]. We further found that a lower CPO reserve had an incremental prognostic value over the H2FPEF score and exercise duration. In contrast, resting CPO did not predict clinical outcomes in patients with HFpEF.METHODS AND RESULTSExercise stress echocardiography was performed in 425 dyspnoeic patients [217 HFpEF and 208 non-heart failure (HF) controls] to estimate CPO at rest and during exercise. We classified patients with HFpEF based on the median value of changes in CPO from rest to peak exercise (ΔCPO >0.49 W/100 g). Patients with HFpEF and a lower CPO reserve had poorer biventricular systolic function, impaired chronotropic response during exercise, and worse aerobic capacity than controls and those with a higher CPO reserve. During a median follow-up of 358 days, a composite outcome of all-cause mortality or HF events occurred in 30 patients. Patients with a lower CPO reserve had four-fold and nearly 10-fold increased risks of the outcomes compared with those with a higher CPO reserve and controls, respectively [hazard ratio (HR) 4.05, 95% confidence interval (CI) 1.16-10.1, P = 0.003 and HR 9.61, 95% CI 3.58-25.8, P < 0.0001]. We further found that a lower CPO reserve had an incremental prognostic value over the H2FPEF score and exercise duration. In contrast, resting CPO did not predict clinical outcomes in patients with HFpEF.A lower CPO reserve was associated with biventricular systolic dysfunction, chronotropic incompetence, exercise intolerance, and adverse outcomes in patients with HFpEF.CONCLUSIONA lower CPO reserve was associated with biventricular systolic dysfunction, chronotropic incompetence, exercise intolerance, and adverse outcomes in patients with HFpEF.
Author Sorimachi, Hidemi
Murakami, Fumitaka
Ishii, Hideki
Kagami, Kazuki
Yuasa, Naoki
Harada, Tomonari
Naito, Ayami
Kato, Toshimitsu
Saito, Yuki
Takizawa, Daiki
Obokata, Masaru
Wada, Naoki
Author_xml – sequence: 1
  givenname: Daiki
  surname: Takizawa
  fullname: Takizawa, Daiki
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 2
  givenname: Tomonari
  surname: Harada
  fullname: Harada, Tomonari
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 3
  givenname: Masaru
  orcidid: 0000-0002-5473-0688
  surname: Obokata
  fullname: Obokata, Masaru
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 4
  givenname: Kazuki
  surname: Kagami
  fullname: Kagami, Kazuki
  organization: Division of Cardiovascular Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan
– sequence: 5
  givenname: Hidemi
  surname: Sorimachi
  fullname: Sorimachi, Hidemi
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 6
  givenname: Naoki
  surname: Yuasa
  fullname: Yuasa, Naoki
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 7
  givenname: Yuki
  surname: Saito
  fullname: Saito, Yuki
  organization: Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
– sequence: 8
  givenname: Fumitaka
  surname: Murakami
  fullname: Murakami, Fumitaka
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 9
  givenname: Ayami
  surname: Naito
  fullname: Naito, Ayami
  organization: Division of Cardiovascular Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan
– sequence: 10
  givenname: Toshimitsu
  orcidid: 0000-0002-0011-7589
  surname: Kato
  fullname: Kato, Toshimitsu
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
– sequence: 11
  givenname: Naoki
  surname: Wada
  fullname: Wada, Naoki
  organization: Department of Rehabilitation Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
– sequence: 12
  givenname: Hideki
  surname: Ishii
  fullname: Ishii, Hideki
  organization: Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37738627$$D View this record in MEDLINE/PubMed
BookMark eNpNUE1Lw0AUXKRia-3Rq-zRS2z2I8nmKMUvKOhBz2GzedtsSLJxd2Mp-OMNtoLvMjPMvIH3LtGstz0gdE3iOxLnbA11o8y6AVlRTs_QgsY8iygndPaPz9HK-yaeJuEpp-QCzVmWMZHSbIG-32So7VAfvLGt3RmFZV_hwdldb32YpOkG64LsFWCrsZKuMlLhwe7BYTuGYQzYgQf3Bdj0uAbpAtbStKMDvDehnrqOdoWhARWM7bF28pdcoXMtWw-rEy7Rx-PD--Y52r4-vWzut5FiNA0R4zQhmSaSpYpxoajKiUryRBBVZpALrWPCQeRVxsusrBSTQotYqTLWQk-7dIluj73TXZ8j-FB0xitoW9mDHX1BRSoIEWlOpujNKTqWHVTF4Ewn3aH4-xj9AbMYdAE
CitedBy_id crossref_primary_10_1253_circrep_CR_25_0067
crossref_primary_10_1016_j_ijcard_2025_133001
crossref_primary_10_1016_j_jjcc_2025_04_007
crossref_primary_10_3179_jjmu_JJMU_R_261
crossref_primary_10_1007_s10396_024_01468_2
crossref_primary_10_62347_KQWC4381
crossref_primary_10_1093_ehjci_jeaf044
crossref_primary_10_1007_s12574_024_00664_w
crossref_primary_10_1016_j_jjcc_2025_01_001
crossref_primary_10_1093_ehjci_jeae152
ContentType Journal Article
Copyright The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/ehjci/jead242
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2047-2412
ExternalDocumentID 37738627
Genre Journal Article
GrantInformation_xml – fundername: Takeda Science Foundation
GroupedDBID ---
.2P
.ZR
08P
0R~
48X
53G
5WD
AABZA
AACZT
AAJKP
AAMVS
AAOGV
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABKDP
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABQNK
ABVGC
ABWST
ABXVV
ABZBJ
ACGFS
ACUFI
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGQXC
AGSYK
AGUTN
AHGBF
AHMMS
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
ATGXG
AVWKF
AXUDD
BAYMD
BCRHZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CGR
CUY
CVF
DAKXR
DILTD
D~K
EBD
EBS
ECM
EE~
EIF
EMOBN
ENERS
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HW0
HZ~
IOX
J21
JXSIZ
KOP
KSI
KSN
MHKGH
NGC
NOMLY
NOYVH
NPM
NU-
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
PAFKI
PEELM
Q1.
Q5Y
RD5
ROX
RUSNO
RXO
SV3
TCURE
TEORI
TJX
X7H
YAYTL
YKOAZ
YXANX
~91
7X8
ID FETCH-LOGICAL-c326t-342517f1a36c348c2c91c59581cb7e98ff014e89d74b7bdc3a8f80ccb0f8f4252
IEDL.DBID 7X8
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001080984700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2047-2412
IngestDate Thu Jul 10 18:56:56 EDT 2025
Mon Jul 21 06:07:35 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords exercise
heart failure with preserved ejection fraction
prognosis
cardiac power output
echocardiography
Language English
License The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c326t-342517f1a36c348c2c91c59581cb7e98ff014e89d74b7bdc3a8f80ccb0f8f4252
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0011-7589
0000-0002-5473-0688
PMID 37738627
PQID 2868118691
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2868118691
pubmed_primary_37738627
PublicationCentury 2000
PublicationDate 2024-01-29
PublicationDateYYYYMMDD 2024-01-29
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-29
  day: 29
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European heart journal cardiovascular imaging
PublicationTitleAlternate Eur Heart J Cardiovasc Imaging
PublicationYear 2024
SSID ssj0000546421
Score 2.4363835
Snippet Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterized by multiple cardiac reserve limitations during exercise. Cardiac power...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 220
SubjectTerms Cardiac Output
Echocardiography - methods
Exercise Test
Exercise Tolerance - physiology
Heart Failure
Humans
Prognosis
Stroke Volume - physiology
Ventricular Function, Left
Title Pathophysiologic and prognostic importance of cardiac power output reserve in heart failure with preserved ejection fraction
URI https://www.ncbi.nlm.nih.gov/pubmed/37738627
https://www.proquest.com/docview/2868118691
Volume 25
WOSCitedRecordID wos001080984700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEBVtUkouSdO0SZq2TKBXs7asXcmnEEpCL1n20MLeFmkkUS_Udne9OeXHZ0Z20lOh0IsvtsCMx6OnNx9PiC_kAiEGrzNvK5upypeZy53LGNt7K5FHxCWxCT2fm-WyWoyE23Ysq3yKiSlQ-xaZI59IMzMF6ycVV93vjFWjOLs6Smi8FPslQRku6dJL88yxEBzhPk7Wl0sDCVQhxzGbdI6fhJ9rrCdrMqVkofa_Acy00dwe_e8rvhGHI8SE68EnjsWL0LwVr-_GJPqJeFgQ6msTpTFEPrCNBy7Ualqe2gz1rwTKyR2gjYDJhxA61lODdtd3ux64aWlzH6BugCWxe4i25gJ3YF4XuvG2h7BOpV4NxM3QQfFO_Li9-f71WzaKMGRIyK7PSsVDzWJhyxmWyqDEqsBpNTUFOh0qEyMdsoKpvFZOO4-lNdHkiC6PJtJa-V7sNW0TzgQoAmNOlUHbHJUzytGjtDv62RRnuZPFubh8suuKnJwzF7YJ7W67-mPZc3E6fJxVN0zjWJWadUul_vAPqy_EgSRQwhSKrD6K_Ui_ePgkXuF9X283n5P30HW-uHsEcXvTZg
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pathophysiologic+and+prognostic+importance+of+cardiac+power+output+reserve+in+heart+failure+with+preserved+ejection+fraction&rft.jtitle=European+heart+journal+cardiovascular+imaging&rft.au=Takizawa%2C+Daiki&rft.au=Harada%2C+Tomonari&rft.au=Obokata%2C+Masaru&rft.au=Kagami%2C+Kazuki&rft.date=2024-01-29&rft.eissn=2047-2412&rft.volume=25&rft.issue=2&rft.spage=220&rft_id=info:doi/10.1093%2Fehjci%2Fjead242&rft_id=info%3Apmid%2F37738627&rft_id=info%3Apmid%2F37738627&rft.externalDocID=37738627
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-2412&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-2412&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-2412&client=summon